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 Reactive oxygen species (ROS) are thought to contrib-
ute to many retinal microvascular diseases, including diabe-
tes [1-3] and retinopathy of prematurity (ROP) [4,5]. Retin-
opathy of prematurity was the leading cause of blindness in
American infants in the late 1940s [6]. Once hyperoxia was
implicated as a causative agent, the exposure of premature
infants to hyperoxia was reduced and, subsequently, the inci-
dence of ROP was greatly diminished [7]. Presently, however,
the number of blinding ROP cases is increasing again, a result
of the larger number of at-risk premature infants surviving
[8]. The only proven treatments for ROP being used clinically
are retinal ablation by laser or cryotherapy. Ablative therapy
causes destruction of the peripheral avascular retina with the
intent of destroying the tissue that is the source of angiogenic
factor. Although successful at reducing the incidence of blind-
ness associated with threshold ROP in some cases, ablation
therapies are associated with reduced visual function [9,10].
The canine model of oxygen-induced retinopathy (OIR)
closely resembles human ROP [10], as suggested by Gole [11].
The extent of vaso-obliteration in response to hyperoxia is
comparable to human and not limited to central retina like the
rodent models. The vasoproliferative response after returning
to room air is robust and of long duration like the human and
not limited to the short window in which angiogenesis occurs
in rodent models. In addition, the neonatal dog eye is compa-
rable in morphology and only slightly smaller in size than pre-
mature human, so it can provide a preclinical forum for evalu-
ation of therapeutic reagents. A potential target for ROP thera-
peutics is hyperoxia-induced oxidative stress.
Oxidative stress levels are communicated through signal-
ing pathways resulting in the induction of antioxidant genes
as a protective measure in cells [12-14]. The cell protects it-
self from oxidative insult through a variety of signaling path-
ways that converge onto the multitude of promoter sequences
found in the genomic DNA. From bacteria to human beings,
oxidative stress can be sensed and responded to by a series of
proteins including powerful antioxidants and support enzymes.
These critical proteins are therapeutic to the cell, in that their
presence helps to eliminate oxidative stress. The regulation of
these genes can be complex, but recent advances have shed
light on some of these pathways. One of these responses is
coordinated through a complex signaling network involving
the antioxidant response element (ARE) [15,16]. The ARE is
composed of a cis-acting enhancer region known as the ARE
that is directly controlled by several factors that include the
transcription factor Nrf2, a repressor Keap1, and small Maf
proteins. This system is endogenously activated through the
actions of oxidative stress on the Keap1 protein [17]. This
protein normally represses the Nrf2 activator by retaining Nrf2
in the cytoplasm. The activated ARE enhances the expression
of any gene downstream of its sequence. The ARE can induce
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a variety of antioxidant and supporting genes (e.g., glutathione
s-transferase and NAD(P)H:quinone oxidoreductases) [18,19].
Zhu et al. [20-22] reported the activity of a series of ARE
repeats using a EGFP reporter. We adapted this system for use
with our nanoparticle-based gene delivery system. This anti-
oxidant response element biosensor approach was chosen be-
cause of its potential to control the expression of therapeutic
genes for endothelial cells in OIR treatment.
The focus of this study was to develop a nonviral meth-
odology for the delivery of therapeutic genes whose expres-
sion would be primarily controlled by the affected cell. This
approach helps to alleviate the expression problems associ-
ated with the use of promoters; for example, CMV expresses
therapeutic or reporter genes at levels far exceeding physi-
ologic levels. Additionally, this approach gives the cell the
ability to regulate the therapeutic gene expression in response
to the levels of the pathogenic process in real time.
Nanoparticles were chosen for these studies, because they have
several advantages over more traditional methods, for example
viral gene delivery. Viral gene delivery is quite efficient in
vitro, but using a virus to deliver genes in vivo is difficult and
there can be complications. One of the problems is that the
natural viral tropism is altered when a virus is used for gene
delivery. Directing a virus to an abnormal host is becoming
more and more common as the technology of pseudotyping
advances, but this targeting methodology is still in the devel-
opment stage. This is done by changing the exposed proteins
on the viral surface. Another problem in this process is the
immunoreactivity of the virus, which is currently being mini-
mized through the development of chimeric viruses [23]. The
transduction efficiency for viral-based gene delivery vectors
is usually determined by fluorescence or clonal selection. In
fact, most if not all of the viral vectors are not replication com-
petent, thus requiring a packaging cell line to be produced.
After production, the virus then needs to be purified from the
contaminants in the cell media [24]. If done incorrectly, the
immunogenicity can be greatly enhanced. In vivo transfec-
tion varies greatly depending on the virus, genetic elements
used, and the tissue treated [24].
On the other hand, magnetic nanoparticles, like the ones
used in this manuscript, do not appear to illicit an immune
response, even when targeted to immune cells [25]. These and
other nanoparticles can be synthesized to carry any number of
molecules, including proteins, DNA, lipids and, organic and
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Figure 1. Construction and anatomy
of magnetic nanoparticles.  A: Con-
jugation of biotin-labeled transcrip-
tionally active PCR products (TAP)
DNA to streptavidin-coated mag-
netic nanoparticles (MNP). A 0.8%
agarose gel stained with ethidium
bromide was used to visualize DNA
and DNA tethered nanoparticles.
The leftmost lane are molecular
weight markers, from 1 to 10 kb
(MW). Lane 1 contains only 5' bi-
otin-tagged TAP DNA (Black rect-
angular outline). Lane 2 is a solu-
tion containing DNA from Lane 1
combined with streptavidin-coated
magnetic nanoparticles. The black
rectangular outline in Lane 2 high-
lights 5' TAP tethered magnetic
nanoparticles. A: Schematic of the
construction of the MNP. B: The
layered anatomy of a lipid coated
DNA tethered nanoparticle. C:
Schematics of the two DNA con-
structs used to assess transfection
and ARE activity.
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inorganic substances [26]. Therefore, the flexibility of the tar-
geting system of a nanoparticle is much greater than that of a
naturally produced virus. Some other advantages of
nanotechnology in this arena are low immunogenicity, multi-
functional components on individual layers (Figure 1), inabil-
ity to reproduce, and biodegradability. In the near future we
will probably design synthetic viruses that carry out simple
targeted gene delivery, but the true benefit from nano-scaled
synthesis will be realized when we make multifunctional nano-
scaled tools to address complex diseases. This study describes,
in detail, the construction and characterization of TAP-teth-
ered magnetic nanoparticles (MNP) for the delivery of genes
in vitro. These data suggest that MNP most efficiently trans-
fect migrating and dividing retinal endothelial cells. Finally,
we show that canine retinal endothelial cells induce a
nanoparticle delivered biosensor activity (ARE) in response
to hyperoxia.
METHODS
Primary culture of adult dog retinal endothelial cells
(ADREC):  Primary cell lines of ADRECs were established as
reported in the companion manuscript and by Lutty et al. [27].
Adult beagles were euthanized by an intraperitoneal overdose
of pentobarbital sodium. Animals were treated in accordance
with the ARVO Statement for the Use of Animals in Oph-
thalmic and Vision Research. The eyes were enucleated and
then soaked in cold Betadine for 15 min. The retina was dis-
sected, washed thoroughly, and homogenized in PBS with a
Dounce homogenizer. The homogenate was filtered with a 105
µm Nitex nylon mesh in a porcelain funnel under a gentle
vacuum. The filtrate was then passed through an 58 µm Nitex
mesh. The vessel retentate was digested in 0.375% collage-
nase and 0.25% bovine serum albumin in PBS for 45-60 min
at 37 °C. The digestion was then stopped by the addition of
DMEM/F12 media supplemented with 10% fetal bovine se-
rum, 1% Penicillin/Streptomycin/Fungizone (Gibco, Inc.,
Rockville, MD). The cells were then incubated at 37 °C in 5%
CO2 for 24 h in a T-25 flask. After 24 h, the unattached cells
and debris were washed away and the remaining cells were
given fresh media. All studies were done with cells less than
passage 10. Cells were 100% positive for vWF and uptake of
acetylated low density lipoprotein.
Adult dog retinal endothelial cells wound healing assay:
A wound healing assay described by Selden et al. [28] was
used for generating quiescent, dividing, and migrating
ADRECs in culture [27]. Cells were first grown to confluence
in 24 well plates and then wounds were made by scraping
laterally across the dish surface with a sterile razor blade. The
edge of the razor scores the plastic dish slightly at the begin-
ning of the stroke and the razor removes all cells in its path.
The wells are rinsed once with PBS, pH 7, to remove the non-
adherent cells and then fresh media added. The cells were then
incubated as above for 48 h prior to treatment. After treatment
with 0, 5, 10, or 20 µl of MNP, the morphology of the cells
was examined and quantified. Quiescent cells are the cells that
were still present in the monolayer after scraping (i.e., were
located behind the scrape line). The dividing and migrating
cells are the cells that have progressed into the region where
cells were removed. Migrating cells were elongated and dis-
played processes, whereas dividing cells were rounded and
raised. Migrating cells are mostly in advance of dividing cells
in the wound repair process [28]. Three fields were photo-
graphed per well and a total of three wells were examined per
group. An example of a field is shown in Figure 2.
Generation of TAP:  PCR amplification was used to cre-
ate biotin-labeled DNA fragments. For initial studies, either
the 5' or the 3' oligonucleotide was made with a single biotin
tag. The sequences were based on the pDsRed-C1 (BD
Clontech, Inc., Mountain View, CA) and pARE templates:
forward 5'-TAG TTA TTA ATA GTA ATC-3', reverse 5'-TAC
ATT GAT GAG TTT GGA-3' (Integrated DNA Technologies,
Inc., Coralville, IA). The pARE template was generously do-
nated by William Fahl (University of Wisconsin, Madison,
WI) and Ming Zhu (Arizona Cancer Center, Tuscon, AZ). Later
studies used only oligonucleotides labeled with a 5' biotin.
These oligonucleotides were then used as PCR primers. For
ARE studies, a typical reaction would include: 25 µl Red Taq,
(5 units, Sigma Chemicals, Inc., St. Louis, MO), 1 µl 5'
biotinylated primer, 1 µl 3' primer, 1 µl template, 5 µl PCR
buffer (containing 100 mM Tris-HCl, pH 8.3, 500 mM KCl,
11 mM MgCl2 and 0.1% gelatin), and 17 µl water. The oligo-
nucleotides were at 200 pM and the template at 50 ng/µl. A
typical reaction for DNA tethering to magnetic nanoparticles
would include about 25 of these reactions. Typical PCR cycles
would include 35 cycles of denaturing at 94 °C for 30 s, an-
nealing at 65 °C for 30 s and extension for 2 min at 72 °C.
Normally, 96 reactions were carried out for each experiment.
MNP construction:  Biotin-labeled TAP were tethered to
streptavidin-coated magnetic nanoparticles (Miltenyi Biotech,
Inc., Auburn, CA; Figure 1). The magnetic nanoparticles were
incubated with the biotin-labeled PCR fragments at about 30
ng of 1.5 kb TAP per 1 µl of nanoparticles. The mixture was
allowed to incubate at room temperature for 30 min. During
that time, the magnetic column (Miltenyi Biotech, Inc.) was
prepared by washing once with 100 µl of the included nucleic
acid buffer and three times with 100 µl Optimem (Gibco, Inc.).
Once washed, the column was loaded with the DNA
nanoparticle mixture. The column was then washed three times
with 100 µl Optimem. The nanoparticles were eluted by re-
moving the column from the magnet and adding 100 µl of
Optimem. The MNP were then coated with lipid
(Lipofectamine 2000, Invitrogen, Inc., Carlsbad, CA). The lipid
coating procedure used the amount of DNA to determine the
quantity of lipid added. For example, when 4 µg of TAP were
tethered to nanoparticles, the eluted nanoparticles were diluted
in 250 µl of Optimem and incubated for 5 min at room tem-
perature. While incubating, 10 µl of lipid was added to an-
other 250 µl of Optimem and incubated for the remaining time.
After 5 min, the two tubes were mixed gently and combined.
This mixture was allowed to stand for 20 min before being
added to the cell culture (i.e., one well of a six well plate).
MNP transfection:  The transfection solution containing
complete MNP in Optimem, was incubated with the cells at
37 °C overnight. For 6 well plates, 500 µl of MNP solution
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(with 4 µg of DNA) was added to 2 ml of normal media in a
single well. After the overnight incubation, the cells were
washed once with PBS and then incubated with complete
media for the remainder of the experiment. This procedure
was carried out for all experiments except for those involving
hyperoxia. For the cells that were exposed to MNP in hyperoxia
experiments, we used a slightly modified transfection proto-
col to yield higher transfection efficiencies while maintaining
viability. For this experiment, the media was removed from a
growing culture in a single 6 well plate and 250 µl the MNP
suspension containing 4 µg of DNA was added to a single
well of a 6 well plate. The cells were then incubated in cell
culture conditions (37 °C in 5% CO2) for 2 h. The plates were
rocked every 10 min to maintain equal dispersion of the MNP.
After 2 h the cultures were washed once with PBS and fed
normal culture medium.
Agarose gel electrophoresis:  Agarose gel (0.8%, Cambrex
Bio Science Rockland, Inc., Rockland, ME) electrophoresis
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Figure 2. Characterization of magnetic
nanoparticle penetration.  Twenty four
h after nanoparticle treatment the cells
were developed for alkaline phos-
phatase activity (pseudocolored
green). A: Phase contrast (top) and
pseudocolored (bottom) micrographs
of a typical field containing quiescent,
dividing, and migrating ADRECs.
Nuclei were counterstained with DAPI
(blue, bottom panel). The scrape line
is visible at the junction between the
quiescent and dividing/migrating cells
(dashed line). This field was part of a
well (from a 24 well plate) that was
treated with 20 µl of alkaline phos-
phatase protein coated nanoparticles.
B: Graphs of data from image analy-
sis of nanoparticle-treated cells. The
cell morphology (quiescent, dividers,
and migrators) was used as a basis for
determining nanoparticle targeting
trends. The mean percent and standard
deviation of positive cells was calcu-
lated from an n=3. At least 2000 cells
were analyzed from each group. The
cells were treated with one of four vol-
umes (µl) of a single preparation of
nanoparticles (0, 5, 10, and 20 µl)
which permitted the dose response to
be determined in various cell morphol-
ogy groups. The inset is a pie chart
showing the proportions of the three
cell types in the samples analyzed.
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was used to visualize DNA and MNP. Electrophoresis was
carried out at 100 V for a minimum of 20 min. The resulting
gel was stained with 5 µg/ml ethidium bromide for 10 min
and then de-stained in deionized water for 10 min. Gels were
visualized and photographed on a UV light box with a Nikon
CoolPix 990 digital camera (Nikon, Inc. Melville, NY). For
naked DNA, 1 µl of DNA or PCR product was mixed with 5
µl of 1X loading buffer (New England Biolabs, Inc., Beverly,
MA) and then loaded onto the gel. For MNP, 5 µl of the MNP
mixture was mixed with 1 µl of 5X loading buffer and then
loaded onto the gel.
Fluorescent microscopy and image analysis:  All fluo-
rescent microscopy was done on a Nikon Eclipse TE2000-U
(Nikon, Inc., Melville, NY). The photomicrographs were taken
with a Spot RT SE camera from Diagnostic Instruments, Inc.,
Sterling Heights, MI. All photomicrographs were taken with
the SPOT Advanced software version 3.5.6 (Diagnostic In-
struments, Inc.). The cells were fixed in 2% paraformalde-
hyde in TBS, pH 7.4, for 10 min and then washed three times
with TBS prior to being photographed. Phase contrast photo-
micrographs were taken with an exposure time of 100 ms and
at a gain of 1. Fluorescent image photography was tailored to
the fluorochrome of interest. Photographs of DsRed or EGFP
containing cells were taken with an exposure time of 1.5 s and
at a gain of 4. This was determined by limiting the exposure
time and gain to levels below saturation in positive control
samples.
DAPI or Hoechst 33342 stained cells were photographed
with an exposure time of 100 ms and at a gain of 1. All images
were saved as full resolution, RGB tiffs. Image analysis was
done with NIH image. For nuclei counts, the tiff image was
imported into NIH image and the threshold function was ap-
plied at a cutoff value of 50. Then, the number of nuclei were
counted using the analyze particles function with a minimum
size of 100. The resulting data was then imported into Excel
(Microsoft, Inc., Redmond, WA) and analyzed. All schemat-
ics were done in Photoshop and Illustrator (Adobe Systems,
Inc., San Jose, CA).
Alkaline phosphatase staining:  For alkaline phosphatase
staining, the cells were first fixed in 2% paraformaldehyde in
tris-buffered saline pH 7 (TBS) for 10 min at room tempera-
ture. Then, the cells were permeabilized with 0.25% triton X-
100 in TBS for 10 min at room temperature. Endogenous al-
kaline phosphatase activity was inhibited with the addition of
10 mM levamisole to the development solution. The MNP
delivered alkaline phosphatase (New England Biolabs, Inc.)
activity was detected with the BCIP/NBT alkaline phosphatase
substrate kit from Vector Labs, Inc. Burlingame, CA. The de-
velopment solution contained 2 drops of the Vector Labs re-
agents A, B, and C in 5 ml of 100 mM Tris-HCl, pH 9.5. This
solution was then filtered through a 0.22 µm syringe filter
prior to use. The cells were washed three times with 100 mM
Tris-HCl, pH 9.5, prior to development. The alkaline phos-
phatase activity was developed for 30 min at room tempera-
ture in the dark. After development, the cells were washed
and stored in TBS at 4 °C. Positive cells contained dark purple
or blue coloration, whereas negative cells had no coloration.
Prussian blue staining:  Prussian blue staining was used
to detect cells that contained magnetic nanoparticles [29]. This
does not imply that the cells contain complete MNP, just the
iron oxide core of the nanoparticle. The cells were fixed and
permeabilized as described above and counterstained with 1
µg/ml Hoechst 33342 for 15 min, prior to Prussian Blue stain-
ing. A staining solution containing equal parts 20% hydro-
chloric acid and 10% potassium ferrocyanide was applied to
cells for 10 to 20 min at room temperature. Positive reactions
generally occurred promptly and looked like blue spots within
the cell. These blue spots are the result of the ferric iron in the
nanoparticles combined with the potassium ferrocyanide to
form ferric-ferrocyanide, which has a bright blue color. Analy-
sis was done by first photographing a field under light and
UV fluorescence, followed by NIH image analysis of the fluo-
rescence images and hand counting the Prussian Blue posi-
tive cells.
Immunocytochemistry:  Cells were transfected with noth-
ing, pEGFP-N1, TAP-EGFP (containing CMV-EGFP-N1-pA),
and MNP-EGFP (containing TAP-EGFP) as described above.
After 24 h, the cells were rinsed with TBS three times and
fixed with 2% paraformaldehyde for 10 min at room tempera-
ture. The cells were then washed three times with TBS and
permeabilized with 0.1% Triton-X 100 for 10 min at room
temperature. The cells were then washed three times with TBS
prior to using an avidin/biotin blocking kit containing Avidin
D and biotin to block free biotin and any available streptavidin
binding sites on the MNP (Vector Laboratories, Burlingame,
CA). After blocking, the cells were washed with TBS and in-
cubated with the primary antibody, goat anti-GFP at 1:10,000
(Abcam, Cambridge, UK) for 2 h at room temperature. After
primary labeling and washing, the cells were incubated with
the secondary antibody at 1:4000, biotinylated mouse anti-
goat IgG (Jackson ImmunoResearch, West Grove, PA) for 30
min at room temperature. The cells were then washed with
TBS and incubated with streptavidin-conjugated alkaline phos-
phatase at 1:2000 (KPL, Gaithersburg, MD) for 30 min at room
temperature. The cells were washed and alkaline phosphatase
activity developed with the BCIP/NBT substrate kit (Vector
Labs) supplemented with 2 mg/5 ml Levamisole (Sigma
Chemicals, Inc.) for 10 min at room temperature. The cells
were then washed with TBS and distilled water prior to analy-
sis. The positive and negative cells were then counted on a
light microscope with a 40x objective. Five fields in three wells
were counted per group and the Student’s t-test used to deter-
mine statistical significance.
Flow cytometry:  After exposing the cells to either
normoxia or hyperoxia for 3 days, the cells were washed once
with PBS and stained with 1 µg/ml Hoechst 33342 for 10 min.
The cells were then photographed. After photo-documenta-
tion, the cells were incubated with 0.1% trypsin for 5 min.
The trypsin was then inhibited by the addition of 5 ml com-
plete media. The cells were then pipetted into a 15 ml conical
tube (Corning, Inc., Corning, NY) and centrifuged at 2000
RPM in a Beckman TJ-6 centrifuge with a Beckman TH-4
rotor for 10 min. The cells were then washed three times with
PBS prior to fixation in cold 70% ethanol in PBS overnight.
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The following day the cells were analyzed on a BD FACScan
using channel FL1 for EGFP fluorescence. The FL1 gain was
set at 350. The resulting data were analyzed on a PC using
WinMDI (The Scripps Research Institute, La Jolla, CA).
RESULTS
Construction and anatomy of MNP:  In early studies, reporter
genes were used to characterize the nanoparticles and their
ability to transfect cells (See companion manuscript). Some
early studies substituted biotin-labeled alkaline phosphatase
as a reporter for biotin-labeled TAP in order to determine the
number and type of cells that contained complete MNP. Fig-
ure 1 is a schematic of the MNP construction (Figure 1A),
depictions of multilayered nanoparticle anatomy (Figure 1B),
and the DNA constructs used in these studies (Figure 1C).
Both 5' (Figure 1A) and 3' labeled TAP, with respect to the
coding direction, were used for constructing MNP. In the com-
panion manuscript, we determined that there were no differ-
ences between the labeling strategies, as far as construction of
the MNP was concerned. The 5' biotin tethered TAP showed
slightly better reporter gene expression than 3' tethered TAP
and, therefore, were used in the following studies. Non bi-
otin-labeled TAP were used as negative control for MNP for-
mation, and as expected did not bind to the magnetic
nanoparticles.
Characterization of MNP transfection:  Observations from
pilot experiments using MNP and cells at different plating
densities suggested that transfection efficiency was greater in
dividing cells, with respect to quiescent cells. This hypothesis
was born out in a study that examined the morphology of cells
containing alkaline phosphatase-coated magnetic nanoparticles
(Figure 2A,B). A wound healing assay was used to generate
quiescent, dividing, and migrating cells from a confluent mono-
layer by scraping and allowing the cells to regrow [27,28].
The junction between the quiescent and dividing/migrating
cells was apparent from the scrape mark and cell migration
preceded proliferation in distance from the wound edge (Fig-
ure 2A) [28]. After 48 h of regrowth, the cells were treated
with alkaline phosphatase coated nanoparticles. After 24 h,
the cells were analyzed for alkaline phosphatase activity
(pseudocolored green in Figure 2A, lower micrograph). In this
example, 29 of 539 quiescent, 17 of 90 dividing, and 16 of 38
migrating cells were positive for complete nanoparticles. These
data describe nanoparticle penetration within specific groups,
including quiescent, dividing, and migrating cells. A dose de-
pendent preference for dividing/migrating cells was observed,
when compared to quiescent cells (Figure 2B). The stock bi-
otin-labeled alkaline phosphatase solution was used at the high-
est dose (20 µl in 1 ml of media) as a negative control and no
positive cells were found in this group. The pie chart inset
shows the average proportion of each cell morphologic type
examined. Even though the quiescent cells outnumbered the
dividing/migrating cells 3 to 1, there were a larger proportion
of dividing/migrating cells positive with nanoparticles than
quiescent cells.
Figure 3 is a breakdown of penetration and transfection
of three different stages of MNP construction in either quies-
cent or dividing/migrating cells. In contrast to Figure 2, Fig-
ure 3 examines the effect of nanoparticle layers on transfec-
tion in quiescent and migrating/dividing cells with respect to
the entire population of cells. The same scrape assay described
above was used to test the hypothesis that the assembly of
layered nanoparticles yields both complete and incomplete
nanoparticles. This technique is important because it is the
first to examine the complex effects of nanoparticle construc-
tion on biological functionality. The graph represents the per-
centage of cells positive for either the iron core, complete
nanoparticle (core, tethered protein, and lipid coating), or trans-
fection (expression of a reporter gene tethered to the
nanoparticle), all normalized to the total number of core posi-
tive cells. Below the bar graph in Figure 3 there are represen-
tative photomicrographs of each group. Each of the groups
were coated with lipid as described above. All MNP have iron
cores, so the cells with MNP could be detected with Prussian
Blue staining. This was interpreted as the total number of
nanoparticles present (Core). The enzymatic activity of alka-
line phosphatase tethered nanoparticles identified cells con-
taining complete nanoparticles (Complete). The supposition
that any cell with alkaline phosphatase activity have complete
nanoparticles can be made because endogenous alkaline phos-
phatase activity was inhibited with levamisole and no cells
treated with alkaline phosphatase alone had any detectible
activity (data not shown). DsRed expression from MNP was
used to determine successfully transfected cells (Transfection).
All of the data points shown in Figure 3 were derived from a
single dose of nanoparticles (20 µl per well). A minimal dose
of nanoparticles was used in an attempt to get as close to one
nanoparticle per cell dose as possible, so that a clear relation-
ship between the groups could be established. Results indi-
cate that there is a decline in the number of positive cells,
after the addition of the first layer. The same trend holds true
regardless of cell morphology, although the loss of efficiency
is more pronounced in the dividing/migrating cells.
Immunocytochemistry for EGFP was used as a very sen-
sitive way to determine the number of MNP transfected cells
versus plasmid and TAP transfected cells. The results of these
experiments showed very similar results and relationships to
those that have used flow cytometry to evaluate transfection
efficiency. The immunocytochemical method has several ben-
efits, including the ability to use enzymatic activity to yield a
sensitive and permanent record. Our results showed that the
non-transfected cells had little background, while the EGFP
positive cells were clearly and very darkly stained. Cells trans-
fected with 400 ng of pEGFP-N1 were 42% positive, while
the TAP transfected cells had 70% fewer positive cells. The
MNP transfected group showed 27% transfection, which was
similar to the results from previous experiments and about
twice the level of the TAP group.
Effect of hyperoxia on reporter gene expression and bio-
sensor activity in ADRECs:  Flow cytometric analysis of ARE-
driven EGFP fluorescence was conducted on ADRECs pooled
from 3 identical experiments. Each group was exposed to no
DNA, plasmid DNA, or MNP 24 h after plating. These cells
were subsequently exposed to normoxia or hyperoxia for 3
621
days. All cells, including non-transfected, controls (Negative)
were incubated in normoxia or hyperoxia for 3 days and then
analyzed for EGFP expression with flow cytometry. The nega-
tive control-derived data gave a background level of fluores-
cence and served to help determine the cutoff for EGFP posi-
tive cells (set at about 5% of the hyperoxic negative group,
Figure 4). The control cell data appeared to have slightly in-
creased fluorescence despite not being exposed to EGFP. This
is most likely due to increasing autofluorescence in stressed
and dying cells. The MNP-treated cells in hyperoxic condi-
tions showed an obvious increase in the number of EGFP posi-
tive cells when compared to the normoxic controls (Figure 4).
The level of biosensor activation in normoxic cells treated with
MNP (false positive) was about 9% lower than that found in
plasmid control cells, 6.28% and 15.22%, respectively. In
hyperoxia, the percentage of GFP positive cells rose to 19.84%
in MNP treated cells and 40.27% in plasmid treated cells. These
data indicate that the MNP is sensitive to hyperoxia (Figure
4). The plasmid DNA-treated cells had higher false positive
and true positive results. The fold increase of GFP positive
cells in hyperoxia, however, was greater for MNP-treated cells
than plasmid-treated cells at 3.16 and 2.65, respectively. Over-
all, these data show that the MNP tethered biosensor was acti-
vated in hyperoxia.
DISCUSSION
Construction and anatomy of MNP:  The construction of the
MNP was fairly straightforward, when compared to some other
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Figure 3. The presence of magnetic nanoparticle components in transfected cells.  These data represent a breakdown of the magnetic nanoparticles
(MNP) components in either quiescent or dividing/migrating cells. This data set was generated by exposing scraped ADRECs to MNP, which
included lipid coated nanoparticles tethered to DsRed DNA (Transfection) or lipid coated nanoparticles tethered to alkaline phosphatase
protein (Complete). The same cells used for the Transfection data were later evaluated for the Core data with Prussian blue staining. Prussian
blue staining (bottom left, arrow head) for iron was used to quantify the number of cells containing nanoparticles (Core) in the MNP treated
cells. The APase activity (bottom center, arrow head) was used as a surrogate for determining the number of cells with complete nanoparticles
(Complete). Cells positive for DsRed were quantified to assess the number of successfully transfected cells (Transfection, bottom right
photomicrograph, where DsRed is red and Hoechst 33342 counterstain is blue). The cells were treated with a minimal dose of nanoparticles
(10 µl per well of a 6 well plate, n=3) and were stained 24 h after nanoparticle treatment. Values are the average of three measurements; error
bars represent the standard error of the mean.
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gene delivery methods. As expected, the biotin-labeled ARE
biosensor did not effect the construction of the MNP. Studies
were designed to determine whether the nanoparticles trans-
fected dividing/migrating more often a quiescent cells. These
data suggest a preference for MNP transfection in dividing
and migrating cells in vitro, which gives valuable insight into
their use in vivo. This suggests that the restructuring of the
cytoskeleton and cytoplasmic membrane that accompanies
division and migration may allow more nanoparticles to gain
entry to the cell. These structural changes could be a key to
enabling the nanoparticles to penetrate cells in vivo. The di-
viding/migrating cells may also be more metabolically active
and, therefore, have increased pinocytosis compared to quies-
cent cells. Whatever the mechanism, these data guided us to
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Figure 4. Activity of MNP tethered biosensor in hyperoxia and overview of this process.  These flow cytometric data confirm that the cell
induces the ARE on the MNP in response to hyperoxic insult, thereby resulting in the increased expression of the ARE driven EGFP reporter.
This experiment illustrates the use of a functional biosensor tethered to a MNP that can detect and report a pathological state. A: Flow
cytometric analysis of biosensor activity. These histograms are from cells exposed to normoxic or hyperoxic conditions, either with or without
the biosensor. The right column contains composite images derived from both the normoxic and hyperoxic histograms. The transfection
groups are a negative control (Negative, no DNA) and MNP-ARE-EGFP are shown in two rows. The y-axis represents events and the X-axis
is GFP fluorescence. The bar indicates the GFP positive region used to calculate the percentage of GFP positive cells. B,C: An overview of the
biosensor tethered nanoparticle in normoxic (B) and hyperoxic (C) conditions. Under normal conditions, the ARE repressor protein Keap1
(red octagon) prevents the ARE activator Nrf2 (green triangle) from leaving the cytoplasm (B). The nanoparticle tethered biosensor (MNP) is
localized in the nucleus and consists of the ARE followed by a EGFP reporter gene (ARE EGFP). When exposed to hyperoxia (C), the cell
experiences oxidative stress. This oxidative insult (yellow) initiates ARE activation by Nrf2 localization in the nucleus, binds to the ARE (thin
arrow), and initiates EGFP expression (thick arrow; C).
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use proliferating cells in order to maximize transfection of the
MNP.
To better understand the limits of this technology we ex-
amined two levels of MNP construction to cell transfection in
a mixed culture of quiescent and dividing/migrating cells.
These data demonstrate for the first time the effects of mul-
tiple layers on magnetic nanoparticle entry into the cell. We
are the first to quantify how many cells have nanoparticles,
how many of those cells carry complete nanoparticles, and
finally the number of cells that are successfully transfected.
These data show that the addition of up to three layers (dext-
ran, streptavidin, and TAP) decreases the number of positive
cells from 6 to 1% and only half of those cells that contained
complete nanoparticles expressed the transfected reporter gene
(accompanying manuscript and Figure 3). These experiments
suggest that the addition of each layer could decrease the trans-
fection efficiency by 50% and this number is halved again if
the particle requires nuclear localization, which is necessary
for transfection. This dramatic stepwise decrease in activity
with the addition of layers makes assembly and purification
paramount to success with these synthetic, nonviral agents for
gene delivery. This information is important because one of
the major benefits of using this technology is the ability to
add multiple layers, with each having different functions.
However, we can use the ability to have multiple layers to add
peptides which enhance uptake, nuclear translocation, and
transfection efficiency in the future.
Effect of ADREC exposure to hyperoxia on reporter gene
expression and biosensor activity:  One of the first steps to-
ward developing this strategy was determining if protein ex-
pression from MNP was altered by hyperoxia. The ARE was
first tested as a plasmid and was found to be induced in cells
exposed to hyperoxia. This suggests that the cells are experi-
encing oxidative stress and are responding by inducing the
expression of cellular antioxidants through the ARE pathway.
Finally, the biosensor was found to be quite functional when
delivered by a MNP. There were also low levels of biosensor
activity in normoxic cells. This may indicate a basal level of
ARE induction normally found in ADRECs.
Collectively, these data show the detailed construction and
characterization of the first biosensor-tethered nanoparticle for
autoregulation of a therapeutic gene. Gel electrophoresis con-
firmed the construction of ARE-tethered magnetic
nanoparticles. Dividing and migrating cells were much more
likely to be transfected by MNP than quiescent cells. This sug-
gests that this approach will be helpful in treating ROP since
migrating cells are organizing to form the retinal vasculature
at the time of hyperoxic insult. Transmission electron micros-
copy images showed most MNP to have perinuclear localiza-
tion (unpublished results). These images also confirmed that
there are differences in core size and the thickness of the lay-
ers. Together these data strongly suggest that MNP construc-
tion was not 100% efficient. Even so, ARE-tethered MNP were
capable of inducing ARE-driven reporter gene expression pri-
marily in the presence of hyperoxia (Figure 4).
These data show that it is possible to deliver a functional
biosensor tethered to a nanoparticle. Furthermore, the multi-
layered nanoparticle system has the advantage of increasing
functionality with additional layers. The next step for this
promising technology is the addition of therapeutic genes and
further optimization for improved transfection prior to mov-
ing into an in vivo ROP model. The ARE is quite appropriate
for controlling a therapeutic gene, since gene expression was
low when the stimulus was not present. Using this system of
therapeutic protein delivery has several benefits, when com-
pared to drug or protein delivery. One of the primary advan-
tages of this system is that the therapeutic agent, in this case a
protein, can be manufactured by the cell in need. This could
help to greatly reduce the need to repeatedly treat the indi-
vidual. Another benefit of using the ARE is the ability of the
individual cell to titer its own drug concentration, thereby treat-
ing only the cells that need the therapeutics. The basal expres-
sion patterns may be a problem if therapeutic gene expression
needs to be kept at a minimum. The problem of high levels of
uninduced expression can be ameliorated by modifying the
promoter construct to match the optimal dosing strategy. Us-
ing this system to treat ROP is valid because many of the cells
in the eye are dividing and migrating during this stage of de-
velopment. This system could then be used to prevent a criti-
cal stage of ROP, vaso-obliteration. The data shown herein
suggests that this biosensor is capable of being activated upon
exposure to hyperoxia. Once activated, the biosensor could
be used to drive a multitude of therapeutic genes, including
those that minimize the cell death associated with vaso-oblit-
eration and this expression will occur only in cells confronted
with oxidative stress. This system also allows one to nano-
invasively monitor therapeutic gene expression via a fluores-
cent reporter. The perfect reporter would be one that has no
toxicity and absorbs and emits in the far red, to escape the
problems associated with autofluorescence. One candidate
gene might be the current generation of DsRed monomers [30].
We are currently investigating several candidate genes for this
task including antioxidants, DNA repair enzymes, and anti-
angiogenics (for example pigment epithelium derived factor).
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